MELANIE KRAMER-HARRINGTON: Open Payments
NPI 1548291982 · KINGSTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 25 payments from 13 companies in 2025. Trend: 2023 $823 · 2024 $516 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $90 |
| Novo Nordisk Inc | 4 | $76 |
| Braeburn Inc. | 3 | $59 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $30 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Corium, LLC | 1 | $27 |
| Indivior Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: Wegovy, BRIXADI, VRAYLAR, Qelbree, QULIPTA, MOUNJARO, JOURNAVX, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
